These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25433291)

  • 1. MicroRNA-1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor-5 (API-5).
    Li D; Liu Y; Li H; Peng JJ; Tan Y; Zou Q; Song XF; Du M; Yang ZH; Tan Y; Zhou JJ; Xu T; Fu ZQ; Feng JQ; Cheng P; chen T; Wei D; Su XM; Liu HY; Qi ZC; Tang LJ; Wang T; Guo X; Hu YH; Zhang T
    FEBS Lett; 2015 Jan; 589(1):68-76. PubMed ID: 25433291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
    Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z
    PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.
    Wu X; Wu S; Tong L; Luan T; Lin L; Lu S; Zhao W; Ma Q; Liu H; Zhong Z
    Scand J Gastroenterol; 2009; 44(11):1332-9. PubMed ID: 19891584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
    Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
    Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1.
    Xu H; Li G; Yue Z; Li C
    Mol Med Rep; 2016 Jun; 13(6):5223-9. PubMed ID: 27108614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
    Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-200b inhibits the proliferation of hepatocellular carcinoma by targeting DNA methyltransferase 3a.
    Li XY; Feng XZ; Tang JZ; Dong K; Wang JF; Meng CC; Wang J; Mo YW; Sun ZW
    Mol Med Rep; 2016 May; 13(5):3929-35. PubMed ID: 26986232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
    Jiang G; Cui Y; Yu X; Wu Z; Ding G; Cao L
    Oncotarget; 2015 Apr; 6(11):9457-66. PubMed ID: 25888635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2.
    Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
    Genet Test Mol Biomarkers; 2015 Jan; 19(1):30-6. PubMed ID: 25494962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
    Li Q; Wang G; Zhang ZM
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity.
    Fang L; Du WW; Yang X; Chen K; Ghanekar A; Levy G; Yang W; Yee AJ; Lu WY; Xuan JW; Gao Z; Xie F; He C; Deng Z; Yang BB
    FASEB J; 2013 Mar; 27(3):907-19. PubMed ID: 23180826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma.
    Deng B; Qu L; Li J; Fang J; Yang S; Cao Z; Mei Z; Sun X
    Sci Rep; 2016 May; 6():26679. PubMed ID: 27230656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
    Chen L; Yao H; Wang K; Liu X
    J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
    Wang Y; Lu Z; Li Y; Ji D; Zhang P; Liu Q; Yao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1076-9. PubMed ID: 25270212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.
    Cui X; Li Q; He Y
    Mol Cell Biochem; 2017 Jan; 424(1-2):195-201. PubMed ID: 27822662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-203 inhibits proliferation of HCC cells by targeting survivin.
    Wei W; Wanjun L; Hui S; Dongyue C; Xinjun Y; Jisheng Z
    Cell Biochem Funct; 2013 Jan; 31(1):82-5. PubMed ID: 22886454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma.
    Karimkhanloo H; Mohammadi-Yeganeh S; Hadavi R; Koochaki A; Paryan M
    Mol Biol Rep; 2020 Oct; 47(10):7429-7437. PubMed ID: 32901357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB.
    Connolly EC; Van Doorslaer K; Rogler LE; Rogler CE
    Mol Cancer Res; 2010 May; 8(5):691-700. PubMed ID: 20460403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
    Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C
    Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.